Riskpilot← Back to searchSign inGet full accessHAVILA BIO AS
ASActiveOrg 930012289Mjølstadnesvegen 24, 6092 FosnavågDemolition · NACE 4311Est. 20220 employees
Revenue 2025
NOK 0
EBITDA margin
—
-8591% vs 2024
Equity ratio
-189932.2%
Financial strength
Net profit 2025
NOK -8,1M
+67% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -5,5M | -8591% |
| Net profit | NOK -8,1M | +67% |
| Total assets | NOK 18K | -34% |
| Equity | NOK -34,1M | -31% |
| Employees | 0 | — |
Legal name
HAVILA BIO AS
Org number
930012289
Legal form
Aksjeselskap
NACE code
4311 · Demolition
Founded
10. oktober 2022
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investere i bio-energi relaterte prosjekter.
Address
Mjølstadnesvegen 24, 6092 Fosnavåg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −30 | −63 | −5 516 |
| Depreciation & amort. | −91 | −0 | −0 | −0 |
| EBIT | −91 | −30 | −63 | −5 516 |
| Net financials | −53 | −999 | −24 873 | −2 601 |
| Profit before tax | −145 | −1 029 | −24 936 | −8 117 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −145 | −1 029 | −24 936 | −8 117 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2 880 | 10 001 | 27 | 18 |
| Equity | −140 | −1 078 | −26 014 | −34 131 |
| Long-term debt | 3 021 | 11 063 | 24 048 | 34 135 |
| Short-term debt | 0 | 16 | 1 993 | 14 |
| Total debt | 3 021 | 11 079 | 26 041 | 34 149 |
EBITDA margin
-551586500.0%
This company
15.8%
Market median
-3491053897% vs market
20222025
Equity ratio
-189932.2%
This company
38.2%
Market median
-497305% vs market
20222025
Return on equity
-811675300.0%
This company
18.4%
Market median
-4411278904% vs market
20222025
Net profit margin
-811675300.0%
This company
8.1%
Market median
-10020682816% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20222025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-10-03 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KE Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hsr Invest As
HAVILA BIO AS Board members of HAVILA BIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Evensgård | Chief Executive Officer | 0 companies |
| Njål Sævik | Board of Directors | 0 companies |
| Anders Myklebust | Chairman | 0 companies |
| Vegard Sævik | Chairman | 0 companies |